Showing results (1221-1230 of 2,148) with videos related to
Sort By:
Pageof 215
Journal of Ovarian Research|November 19, 2019
Comparison of the umbilical cord Blood's anti-Mullerian hormone level in the newborns of mothers with polycystic ovary syndrome (PCOS) and healthy mothersFaezeh Tadaion Far, Shahideh Jahanian Sadatmahalleh, Saeideh Ziaei, et al.Journal of Ovarian Research|November 29, 2019
Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from ChinaJing Ni, Xianzhong Cheng, Rui Zhou, et al.Journal of Ovarian Research|November 16, 2019
Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysisJiayu Shen, Shuqian Yu, Xiwen Sun, et al.Journal of Ovarian Research|July 12, 2021
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progressionZhongyu Wang, Yake Huang, Ling Long, et al.Journal of Ovarian Research|June 21, 2021
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysisYuqiang Zhang, Sufen Cao, Chunyu Zhuang, et al.Journal of Ovarian Research|June 21, 2021
Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndromeZhihong Zhang, Min Sang, Siqin Liu, et al.Journal of Ovarian Research|July 21, 2021
Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolismYi Zhang, Yuxin Ran, Lingna Kong, et al.Journal of Ovarian Research|December 9, 2020
Ovarian fibrosarcoma: A single-institution experience and a review of the literatureTing-Ting Sun, Ning-Hai Cheng, Dong-Yan Cao, et al.Journal of Ovarian Research|May 14, 2013
Lung cancer diagnosis on ovary mass: a case reportNunzia Simona Losito, Cono Scaffa, Monica Cantile, et al.Journal of Ovarian Research|May 14, 2013
Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogsKellie S Rath, Georgia A McCann, David E Cohn, et al.Pageof 215